Safety and Efficacy of a Weekly Oral Cyclic Antibiotic Programme in the Prevention of Urinary Tract Infection on Neurological Bladder

PHASE4CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

January 31, 2016

Study Completion Date

February 28, 2017

Conditions
Neurogenic BladderUrinary Tract Infection
Interventions
DRUG

Weekly Oral Cyclic Antibiotic programme

The Weekly Oral Cyclic Antibiotic Programme consisted of the alternate administration of an antibiotic once per week. The antibiotics that were chosen (efficient for urinary tract infection, well tolerated, low selection pressure) included : Amoxicillin 6000 mg, Amoxicillin/clavulanic acid 3000 mg, Cefixime 400 mg, Fosfomycin trometamol 6000 mg, Trimethoprim/sulfamethoxazole 2400 mg. During week A,the patient received a single antibiotic (A), and the following week B the patient was given another antibiotic (B). For each patient, antibiotics were specifically chosen according to the results of urine cultures.

Trial Locations (4)

35000

University Hospital, Pontchaillou / RENNES, Rennes

37000

University Hospital, Bretonneau / TOURS, Tours

44000

University Hospital, St Jacques / NANTES, Nantes

92380

University Hospital, Raymond Poincaré / APHP, Garches

All Listed Sponsors
lead

University Hospital, Tours

OTHER

NCT01388413 - Safety and Efficacy of a Weekly Oral Cyclic Antibiotic Programme in the Prevention of Urinary Tract Infection on Neurological Bladder | Biotech Hunter | Biotech Hunter